Published in Br J Clin Pharmacol on December 01, 2009
Epidemiologic and genetic aspects of spina bifida and other neural tube defects. Dev Disabil Res Rev (2010) 1.96
Genetic, epigenetic, and environmental contributions to neural tube closure. Annu Rev Genet (2014) 0.99
Nongenetic risk factors and congenital heart defects. Pediatr Cardiol (2013) 0.90
Identifying women who might benefit from higher doses of folic acid in pregnancy. Can Fam Physician (2012) 0.84
Safety of cotrimoxazole in pregnancy: a systematic review and meta-analysis. J Acquir Immune Defic Syndr (2014) 0.81
Trimethoprim-sulfonamide use during the first trimester of pregnancy and the risk of congenital anomalies. Pharmacoepidemiol Drug Saf (2015) 0.77
Folic acid supplementation for pregnant women and those planning pregnancy: 2015 update. J Clin Pharmacol (2015) 0.75
Maternal periconceptional occupational pesticide exposure and neural tube defects. Birth Defects Res A Clin Mol Teratol (2014) 0.75
Finding the genetic mechanisms of folate deficiency and neural tube defects-Leaving no stone unturned. Am J Med Genet A (2017) 0.75
Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet (1980) 10.23
Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med (1999) 6.27
Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med (2000) 5.37
Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol (2003) 3.75
Use of Medicaid data for pharmacoepidemiology. Am J Epidemiol (1989) 3.11
The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention. Birth Defects Res A Clin Mol Teratol (2003) 1.58
Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol (2001) 1.51
Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet (1996) 1.50
Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies. Epidemiology (1995) 1.49
The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study. Reprod Toxicol (2001) 1.29
Genetic disorders among Palestinian Arabs: 1. Effects of consanguinity. Am J Med Genet (1997) 1.18
Birth defects and parental consanguinity in Norway. Am J Epidemiol (1997) 1.17
The safety of metoclopramide use in the first trimester of pregnancy. N Engl J Med (2009) 1.07
Effects of antibacterials on the unborn child: what is known and how should this influence prescribing. Paediatr Drugs (2001) 0.95
The safety of nitrofurantoin during the first trimester of pregnancy: meta-analysis. Fundam Clin Pharmacol (1995) 0.94
Drugs and folate metabolism. Drugs (1985) 0.87
Folic acid sensitive birth defects in association with intrauterine exposure to folic acid antagonists. Reprod Toxicol (2005) 0.85
Decisions regarding pregnancy termination among Bedouin couples referred to third level ultrasound clinic. Eur J Obstet Gynecol Reprod Biol (1998) 0.85
The incidence of anemia in an Israeli population: a population analysis for anemia in 34,512 Israeli infants aged 9 to 18 months. Pediatrics (2006) 0.83
Maternal factors associated with severity of birth defects. Int J Gynaecol Obstet (1999) 0.82
Prevalence of depression during pregnancy: systematic review. Obstet Gynecol (2004) 5.42
Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry (2013) 3.71
Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study. Int J Epidemiol (2013) 3.68
Central nervous system depression of neonates breastfed by mothers receiving oxycodone for postpartum analgesia. J Pediatr (2011) 2.86
Variables associated with medication errors in pediatric emergency medicine. Pediatrics (2002) 2.86
Gestational diabetes: the need for a common ground. Lancet (2009) 2.80
Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can (2007) 2.64
Single-dose and steady-state pharmacokinetics of celecoxib in children. Clin Pharmacol Ther (2002) 2.53
Perinatal risks of untreated depression during pregnancy. Can J Psychiatry (2004) 2.50
Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis. Neurology (2014) 2.41
Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med (2002) 2.32
Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes. Am J Obstet Gynecol (2012) 2.23
Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study. J Clin Psychiatry (2008) 2.22
The Association Between Hospital Readmission and Pulmonologist Follow-up Visits in Patients With COPD. Chest (2015) 2.05
The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. BJOG (2004) 2.04
The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis. Am J Gastroenterol (2009) 2.03
FDA pregnancy risk categories and the CPS: do they help or are they a hindrance? Can Fam Physician (2010) 2.02
Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry (2008) 2.01
Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry (2005) 2.00
Liposomal lidocaine to improve procedural success rates and reduce procedural pain among children: a randomized controlled trial. CMAJ (2005) 1.99
Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors. Clin Ther (2007) 1.98
Role of fetal length in the prediction of fetal weight. J Ultrasound Med (2012) 1.97
Mutation of TBCE causes hypoparathyroidism-retardation-dysmorphism and autosomal recessive Kenny-Caffey syndrome. Nat Genet (2002) 1.96
Mechanisms of cardiac arrhythmias and sudden death in transgenic rabbits with long QT syndrome. J Clin Invest (2008) 1.93
Folic acid food fortification is associated with a decline in neuroblastoma. Clin Pharmacol Ther (2003) 1.91
Population baseline of meconium fatty acid ethyl esters among infants of nondrinking women in Jerusalem and Toronto. Ther Drug Monit (2003) 1.91
Measurement of cortisol in human hair as a biomarker of systemic exposure. Clin Invest Med (2007) 1.91
Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology. Ther Drug Monit (2009) 1.89
Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Am J Psychiatry (2012) 1.88
Safety of codeine during breastfeeding: fatal morphine poisoning in the breastfed neonate of a mother prescribed codeine. Can Fam Physician (2007) 1.83
Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil Steril (2006) 1.80
Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction. Stem Cells (2008) 1.78
Hair cortisol as a biological marker of chronic stress: current status, future directions and unanswered questions. Psychoneuroendocrinology (2011) 1.78
Child neurodevelopmental outcome and maternal occupational exposure to solvents. Arch Pediatr Adolesc Med (2004) 1.77
Rates of spontaneous and therapeutic abortions following use of antidepressants in pregnancy: results from a large prospective database. J Obstet Gynaecol Can (2009) 1.76
Critical analysis of risk factors and outcome of placenta previa. Arch Gynecol Obstet (2010) 1.73
Stress pathways to spontaneous preterm birth: the role of stressors, psychological distress, and stress hormones. Am J Epidemiol (2009) 1.72
Favorable pregnancy outcome following Trastuzumab (Herceptin) use during pregnancy--Case report and updated literature review. Reprod Toxicol (2007) 1.70
Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry (2002) 1.68
Historical perspective: the original description of fetal alcohol spectrum disorder in France, 1967. Ther Drug Monit (2003) 1.68
The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. J Clin Psychiatry (2013) 1.67
The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis. J Clin Psychiatry (2013) 1.66
Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence. J Clin Psychiatry (2013) 1.65
Pregnancy outcome following non-obstetric surgical intervention. Am J Surg (2005) 1.65
Codeine-acetaminophen versus nonsteroidal anti-inflammatory drugs in the treatment of post-abdominal surgery pain: a systematic review of randomized trials. Am J Surg (2009) 1.65
More codeine fatalities after tonsillectomy in North American children. Pediatrics (2012) 1.63
Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology (2005) 1.62
Estradiol promotes sudden cardiac death in transgenic long QT type 2 rabbits while progesterone is protective. Heart Rhythm (2012) 1.62
Counseling about medication-induced birth defects with clinical decision support in primary care. J Womens Health (Larchmt) (2013) 1.60
Pregnancy and isotretinoin therapy. CMAJ (2013) 1.60
Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience. Drug Saf (2002) 1.58
Codeine, ultrarapid-metabolism genotype, and postoperative death. N Engl J Med (2009) 1.57
Discrepancies between ordered and delivered concentrations of opiate infusions in critical care. Crit Care Med (2003) 1.55
Breast-feeding during maternal use of azathioprine. Ann Pharmacother (2006) 1.52
Hair mercury levels of women of reproductive age in Ontario, Canada: implications to fetal safety and fish consumption. J Pediatr (2010) 1.52
A randomized cross over trial of tolerability and compliance of a micronutrient supplement with low iron separated from calcium vs high iron combined with calcium in pregnant women [ISRCTN56071145]. BMC Pregnancy Childbirth (2006) 1.50
Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbits. Heart Rhythm (2013) 1.50
Prediction of milk/plasma concentration ratio of drugs. Ann Pharmacother (2003) 1.48
Perineal massage during pregnancy: a prospective controlled trial. Isr Med Assoc J (2008) 1.47
Hair methylmercury: a new indication for therapeutic monitoring. Ther Drug Monit (2010) 1.44
Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: a therapeutic opportunity? Crit Care Med (2002) 1.44
Safety of the newer class of opioid antagonists in pregnancy. Can Fam Physician (2014) 1.43
Outcome following high-dose methotrexate in pregnancies misdiagnosed as ectopic. Am J Obstet Gynecol (2011) 1.43
Colchicine poisoning: the dark side of an ancient drug. Clin Toxicol (Phila) (2010) 1.43
Evaluation of drug formularies for pediatric intensive care. Pediatr Crit Care Med (2011) 1.42
Physicians' perceptions of teratogenic risk associated with radiography and CT during early pregnancy. AJR Am J Roentgenol (2004) 1.42
Patterns of paediatric analgesic use in Africa: a systematic review. Arch Dis Child (2012) 1.42
Treatment satisfaction of diabetic patients: what are the contributing factors? Fam Pract (2009) 1.41
Timolol concentrations in breast milk of a woman treated for glaucoma: calculation of neonatal exposure. J Glaucoma (2008) 1.41
Tdap vaccination during pregnancy to reduce pertussis infection in young infants. Can Fam Physician (2013) 1.40
Characteristics and publication patterns of obstetric studies registered in ClinicalTrials.gov. J Clin Pharmacol (2013) 1.40
Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study. J Clin Psychopharmacol (2012) 1.40
Examining the health and drug exposures among Canadian children residing in drug-producing homes. J Pediatr (2011) 1.39
Electric shock during pregnancy. Can Fam Physician (2003) 1.39
Influenza vaccination during pregnancy. Can Fam Physician (2002) 1.39
Terlipressin for children with extremely low cardiac output after open heart surgery. Ann Pharmacother (2009) 1.39
"Cardiac memory": a struggle against forgetting. Circ Res (2003) 1.39
Eating fish during pregnancy. Risk of exposure to toxic levels of methylmercury. Can Fam Physician (2002) 1.37
Maternal urinary tract infection: is it independently associated with adverse pregnancy outcome? J Matern Fetal Neonatal Med (2009) 1.36
Prospective observational study on the incidence of medication errors during simulated resuscitation in a paediatric emergency department. BMJ (2004) 1.35
Gender does matter in perinatal medicine. Fetal Diagn Ther (2004) 1.34
Modulation of celecoxib pharmacokinetics by food in pediatric patients. Clin Pharmacol Ther (2005) 1.33
Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women. CMAJ (2009) 1.32
Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol (2005) 1.29
Maternal obesity as an independent risk factor for caesarean delivery. Paediatr Perinat Epidemiol (2004) 1.29
Obstetric risk factors and outcome of pregnancies complicated with early postpartum hemorrhage: a population-based study. J Matern Fetal Neonatal Med (2005) 1.29
Treatment of nausea and vomiting in pregnancy: an updated algorithm. Can Fam Physician (2007) 1.29
Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis. BMJ (2014) 1.28
The relationship between stress and hair cortisol in healthy pregnant women. Clin Invest Med (2007) 1.26
Systematic evaluation of errors occurring during the preparation of intravenous medication. CMAJ (2008) 1.26
Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol (2002) 1.25
Topical 4% amethocaine gel reduces the pain of subcutaneous measles-mumps-rubella vaccination. Pediatrics (2004) 1.25
Lethal contractural syndrome type 3 (LCCS3) is caused by a mutation in PIP5K1C, which encodes PIPKI gamma of the phophatidylinsitol pathway. Am J Hum Genet (2007) 1.25
Pharmacogenetic insights into codeine analgesia: implications to pediatric codeine use. Pharmacogenomics (2008) 1.24
Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. Cancer Epidemiol (2010) 1.23
International trends of Down syndrome 1993-2004: Births in relation to maternal age and terminations of pregnancies. Birth Defects Res A Clin Mol Teratol (2010) 1.22
Malformation rates in children of women with untreated epilepsy: a meta-analysis. Drug Saf (2004) 1.21